RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
Regenerative Medical Technologies Group, Inc. (OTC:RMTG), a global leader in regenerative medicine solutions, today announced the successful introduction of its CELLGENIC Peptide Pen product line, officially presented during the ISSCA Global Summit held in Cancún. The new line represents an important step toward simplifying and modernizing peptide therapy within the field of regenerative and longevity medicine, while creating additional revenue...
Read more








